AFTER HITING first target it may consolidate
Also,it may give a heavy rise if it breaks it directly or after consolidating.
🤓
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
RELIANCE
2,109.5
-15.1 (-0.71%)
Updated 03:29 22/10 IST
RELIANCE Buy or Sell - FrontPage Forums
29 Users have submitted 33 trade ideas of Rs. 7,566,337.2 for RELIANCE
Disclaimer88% Bullish
12% Bearish
RELIANCE Buy or Sell - Brokerage Reports
No. of reports in last year
18
No. of analysts
5
Average Consensus Forecast
1724.94
Consensus Potential
-24.98%
RELIANCE Ratings
Long term RELIANCE rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
4.5/5 (4 Ratings)
Find answers to all your questions on live RELIANCE message board: Is RELIANCE buy or sell? Should I buy RELIANCE shares? Why are RELIANCE shares falling? Should I invest in RELIANCE stock?
- Home
- RELIANCE Forum
RELIANCE Share Price Discussion
N
Reputation: 7,036 • Today 12:38 PM
Bharti Infratel Q2 net drops 24% to Rs 733 crore
Consolidated revenue grew by about 2 percent to Rs 3,695 crore during the reported quarter from Rs 3,638 crore earlier, the company said.
Consolidated revenue grew by about 2 percent to Rs 3,695 crore during the reported quarter from Rs 3,638 crore earlier, the company said.
Moneycontrol
Like
Reply
K
Reputation: 6,650 • Today 12:37 PM
Like
Reply
N
Reputation: 7,036 • Today 12:31 PM
FIIs hike stake in Reliance Industries to record 27.2%
Reliance Industries (RIL) on Thursday filed a statement showing the shareholding pattern for the quarter ended September 30.
Reliance Industries (RIL) on Thursday filed a statement showing the shareholding pattern for the quarter ended September 30.
The Economic Times
Like
Reply
D
Reputation: 40,682 • Today 12:30 PM
FII Derivative Market Activity (Oct 22, 2020)
Index Futures: Rs. -318.56 Crores
Index Options: Rs. -769.58 Crores
Stock Futures: Rs. -29.97 Crores
Stock Options: Rs. 77.68 Crores
FNO Banlist (Oct 22, 2020)
BHEL
CANBK
IBULHSGFIN
IDEA
MINDTREE
NATIONALUM
PNB
Like
Reply
N
Reputation: 7,036 • Today 12:28 PM
Alembic Pharma Q2 net profit up 35% at Rs 333 crore on robust sales
Consolidated revenue from operations stood at Rs 1,457.10 crore for the quarter under consideration.
Consolidated revenue from operations stood at Rs 1,457.10 crore for the quarter under consideration.
Moneycontrol
Like
Reply
P
Reputation: 22,767 • Today 12:20 PM
Prakash Kumar Singh in MCX-NATURALGASTrade entered: Sell NATURALGAS 27OCT20 FUT @221...
Next cup & handle pattern sale & sleep #NATURALGAS
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
RELIANCE Share Price - Technicals
- NewsBotToday 12:31 PMFIIs hike stake in Reliance Industries to record 27.2%The Economic TimesNewsBotToday 10:16 AM
Qualcomm optimistic about India's 5G prospects, expects high-velocity progressThe Economic TimesNewsBotToday 7:31 AM
Is it time to opt for domestic economy stocks over pharma?The Economic TimesNewsBotToday 6:11 AM
FPIs, promoters hiked stake in Reliance Industries in Q2The Economic TimesNewsBotOct 20 3:28 AM
Reliance Jio, Qualcomm successfully test 1 Gbps 5G speed in IndiaMoneycontrolNewsBotOct 20 4:36 AM
Bear-bull tug of war underway; profit booking likely around 12,000 levelThe Economic TimesNewsBotOct 20 2:51 AM
Despite a sharp runup, these 3 pharma stocks can be good betsThe Economic TimesNewsBotOct 19 2:16 AM
Working hard to transform India into a digital society: Mukesh AmbaniThe Economic TimesNewsBotOct 19 1:08 AM
Open to further stimulus, assessing impact of the COVID-19 pandemic on FY21: Nirmala SitharamanMoneycontrolNewsBotOct 19 5:51 AM
PM Modi to inaugurate annual India Energy Forum next weekThe Economic Times
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.